ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 3734

$1.15M Total Retail Price of All Prescriptions

Rank: 59 out of 3734

300 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 15,679 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 944 883 1 2
WARFARIN SODIUM 755 676 2 10
FUROSEMIDE 633 559 3 7
OMEPRAZOLE 555 468 4 4
CITALOPRAM HBR 492 413 5 16
LISINOPRIL 450 420 6 3
POTASSIUM CHLORIDE 435 435 7 19
LANTUS 398 324 8 54
DONEPEZIL HCL 381 368 9 25
METOPROLOL TARTRATE 367 301 10 6
QUETIAPINE FUMARATE 334 274 11 82
FENTANYL 322 318 S2 12 65
RISPERIDONE 316 238 13 62
GABAPENTIN 312 246 14 17
SIMVASTATIN 279 217 15 1
KLOR-CON M20 267 235 16 48
ALBUTEROL SULFATE 240 147 17 128
HUMULIN R 236 220 18 273
BUMETANIDE 228 207 19 78
IPRATROPIUM BROMIDE 214 127 20 220
MIRTAZAPINE 213 206 21 45
POLYETHYLENE GLYCOL 3350 202 202 22 53
CYMBALTA 201 171 23 67
AMLODIPINE BESYLATE 186 172 24 5
HYDROCODONE-ACETAMINOPHEN 183 137 S3 25 12
CELEBREX 182 181 26 69
PREDNISONE 168 133 27 42
DIVALPROEX SODIUM 167 72 28 99
PRANDIN 162 162 29 166
TAMSULOSIN HCL 156 133 30 29
TRAMADOL HCL 145 140 31 20
KLOR-CON M10 140 99 32 115
ATENOLOL 140 133 32 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 137 134 34 117
DIGOXIN 135 120 35 43
VENLAFAXINE HCL ER 132 117 36 84
CARBIDOPA-LEVODOPA 129 127 37 92
BUDESONIDE 127 98 38 231
RANITIDINE HCL 127 117 38 32
NAMENDA 124 124 40 44
HYDROCHLOROTHIAZIDE 120 98 41 9
SEROQUEL 119 99 42 161
OXYCODONE-ACETAMINOPHEN 118 89 S2 43 51
FLUTICASONE PROPIONATE 112 101 44 46
ABILIFY 110 84 45 159
SPIRIVA 109 65 46 40
ADVAIR DISKUS 104 89 47 35
SINGULAIR 102 75 48 95
SERTRALINE HCL 100 85 49 18
BUSPIRONE HCL 96 78 50 129
NOVOLIN R 92 92 51 215
LEVOFLOXACIN 89 63 52 116
METOCLOPRAMIDE HCL 86 70 53 158
CLOPIDOGREL 85 67 54 23
OLANZAPINE 81 51 55 106
DILTIAZEM HCL 80 70 56 261
FLUOXETINE HCL 78 47 57 61
DIOVAN 77 73 58 31
DETROL LA 73 58 59 153
TRAZODONE HCL 73 57 59 49
LEVETIRACETAM 70 38 61 105
LAMOTRIGINE 69 69 62 169
ZOLPIDEM TARTRATE 67 50 63 24
NYSTATIN 67 36 63 162
LOPERAMIDE 64 56 65 251
BUPROPION HCL SR 60 48 66 165
ALLOPURINOL 59 59 67 33
RESTASIS 59 59 67 325
ATORVASTATIN CALCIUM 58 56 69 11
CLOTRIMAZOLE-BETAMETHASONE 58 49 69 135
AZITHROMYCIN 58 47 69 38
ARICEPT 57 57 72 363
ISOSORBIDE MONONITRATE ER 56 53 73 34
VANCOMYCIN HCL 56 55 73 323
AMOX TR-POTASSIUM CLAVULANATE 55 47 75 164
HYDRALAZINE HCL 55 13 75 111
NEXIUM 54 47 77 36
PRIMIDONE 53 30 78 274
AMOXICILLIN 53 52 78 108
MORPHINE SULFATE 52 47 S2 80 220
XOPENEX 52 48 80 458
QUINAPRIL HCL 51 46 82 74
BENZTROPINE MESYLATE 51 38 R 82 173
LIDODERM 50 50 84 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.